FMR LLC 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 09:55 am Sale | 2024-11-08 | 13G | Edgewise Therapeutics, Inc. EWTX | FMR LLC | 653,207 0.696% | -4,127,355 (-86.34%) | Filing |
| 2024-07-10 10:10 am Sale | 2024-07-09 | 13G | Edgewise Therapeutics, Inc. EWTX | FMR LLC | 4,780,562 5.118% | -1,711,951 (-26.37%) | Filing |
| 2024-02-09 09:03 am Sale | 2024-02-08 | 13G | Edgewise Therapeutics, Inc. EWTX | FMR LLC | 6,492,513 10.230% | -2,096,716 (-24.41%) | Filing |
| 2023-02-09 10:59 am Purchase | 2023-02-09 | 13G | Edgewise Therapeutics, Inc. EWTX | FMR LLC | 8,589,229 13.587% | 612,416 (+7.68%) | Filing |
| 2022-10-11 09:03 am Purchase | 2022-10-07 | 13G | Edgewise Therapeutics, Inc. EWTX | FMR LLC | 7,976,813 12.631% | 5,476,714 (+219.06%) | Filing |
| 2022-02-09 09:11 am Purchase | 2022-02-08 | 13G | Edgewise Therapeutics, Inc. EWTX | FMR LLC | 2,500,099 5.071% | 2,500,099 (New Position) | Filing |